|
Inflammatory Bowel Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The mucin gene, MUC5AC, is highly expressed both in chronic respiratory inflammatory diseases and inflammatory bowel disease where mucin secretion is regulated by members of the interleukin IL-20 subfamily.
|
31379870 |
2019 |
|
De Quervain Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Correlation Between IL-20 and De Quervain's Disease Severity.
|
30540601 |
2019 |
|
Disorder of tendon
|
0.010 |
Biomarker
|
group |
BEFREE |
The main purpose of our study was to investigate the correlation between IL-20 and tumor necrosis factor (TNF-α) and clarify the potential predictor of tendinopathy progression.
|
30540601 |
2019 |
|
Intraocular pressure disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Additionally, we determined the effects of IL-20 family cytokines on outflow rates in anterior segment perfusion culture, an in vitro model of intraocular pressure (IOP) regulation.
|
31205408 |
2019 |
|
Tendinopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
The main purpose of our study was to investigate the correlation between IL-20 and tumor necrosis factor (TNF-α) and clarify the potential predictor of tendinopathy progression.
|
30540601 |
2019 |
|
Arthritis, Psoriatic
|
0.010 |
Biomarker
|
disease |
BEFREE |
This review describes the IL-20 family of cytokines in rheumatoid arthritis (RA) and spondyloartrhitits (SpA) including psoriatic arthritis.
|
30319661 |
2018 |
|
Behcet Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No statistically significant difference was detected between the IL-20 levels of the control group and the inactive BD patient group (p = 0.2).
|
30048054 |
2018 |
|
Intestinal Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The Interleukin-20 Cytokines in Intestinal Diseases.
|
29967613 |
2018 |
|
Liver diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
In this review, we focus on exploring the role of the IL-20 subfamily of cytokines in viral hepatitis, ALD, non-alcoholic steatohepatitis, and hepatocellular carcinoma, as well as delineating the main strategies explored so far in terms of therapeutic possibilities of the IL-20 subfamily of cytokines in liver disease.
|
29892294 |
2018 |
|
Pneumococcal Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
In the current study, our aim was to demonstrate the implication of IL-20 cytokines and their receptors and their role during experimental pneumococcal infection.
|
30361066 |
2018 |
|
Pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Production of Interleukin-20 cytokines limits bacterial clearance and lung inflammation during infection by Streptococcus pneumoniae.
|
30361066 |
2018 |
|
Kidney Failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
IL-20 is emerging as a potent angiogenic, chemotactic, and proinflammatory cytokine related to several chronic inflammatory disorders likes psoriasis, atherosclerosis, and renal failure.
|
29999545 |
2018 |
|
Tuberculosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
This suggests that the IL-20 subfamily of cytokines, similar to IL-10 might play a potentially crucial role in the modulation of T cell responses in active TB disease.
|
29684756 |
2018 |
|
Viral hepatitis
|
0.010 |
Biomarker
|
group |
BEFREE |
In this review, we focus on exploring the role of the IL-20 subfamily of cytokines in viral hepatitis, ALD, non-alcoholic steatohepatitis, and hepatocellular carcinoma, as well as delineating the main strategies explored so far in terms of therapeutic possibilities of the IL-20 subfamily of cytokines in liver disease.
|
29892294 |
2018 |
|
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In addition, anti-IL-20 mAb may attenuate the effect of IL-20 and suppress liver tumorigenesis <i>in vitro</i> and <i>in vivo</i>, indicating that anti-IL-20 mAbs may potentially serve as effective therapeutic agents for HCC.
|
30333881 |
2018 |
|
Lumbar spondylolisthesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis.
|
30250404 |
2018 |
|
Infectious Lung Disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Collectively, this study highlights the implication of IL-20 related cytokines during lung infection by S. pneumoniae and might have therapeutic applications in bacterial pneumonia.
|
30361066 |
2018 |
|
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications.
|
29999545 |
2018 |
|
Pneumonitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Production of Interleukin-20 cytokines limits bacterial clearance and lung inflammation during infection by Streptococcus pneumoniae.
|
30361066 |
2018 |
|
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Our results expand upon the current understanding of the regulatory mechanism of IL-20 in cancer.
|
28514748 |
2017 |
|
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
HCC tumor tissue expressed higher levels of IL-20 than did non-tumor tissue.
|
29242565 |
2017 |
|
Degenerative polyarthritis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RTQ-PCR and western blotting were used to determine IL-20-regulated OA-associated gene expression in OASFs and OACCs.
|
28426699 |
2017 |
|
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The findings of this study suggest that IL-20 plays a role in the tumor progression of HCC.
|
29242565 |
2017 |
|
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Our results expand upon the current understanding of the regulatory mechanism of IL-20 in cancer.
|
28514748 |
2017 |
|
Diabetic foot ulcer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our data suggest that IL-20 subfamily cytokines, particularly IL-20, IL-22, and IL-24, might provide therapeutic benefit for patients with DFU.
|
28125663 |
2017 |